{
  "stories": [
    {
      "by": "ColinWright",
      "descendants": 0,
      "id": 28359321,
      "score": 1,
      "time": 1630349009,
      "title": "Facebook’s Secret War on Switching Costs",
      "type": "story",
      "url": "https://www.eff.org/deeplinks/2021/08/facebooks-secret-war-switching-costs"
    },
    {
      "by": "wensley",
      "descendants": 0,
      "id": 28359316,
      "score": 1,
      "time": 1630348997,
      "title": "Plan to use ozone to disinfect classrooms in Wales",
      "type": "story",
      "url": "https://www.theguardian.com/uk-news/2021/aug/30/concerns-over-plan-to-disinfect-classrooms-in-wales-with-ozone"
    },
    {
      "by": "rmason",
      "descendants": 0,
      "id": 28359297,
      "score": 1,
      "time": 1630348908,
      "title": "Why your first customer is worth $10M",
      "type": "story",
      "url": "https://www.ejorgenson.com/blog/why-your-first-customer-is-worth-10000000"
    },
    {
      "by": "arturi",
      "descendants": 0,
      "id": 28359287,
      "score": 1,
      "time": 1630348830,
      "title": "Uppy File Uploader 2.0: smaller and faster, Preact X, stricter TypeScript types",
      "type": "story",
      "url": "https://uppy.io/blog/2021/08/2.0/"
    },
    {
      "by": "ewag",
      "descendants": 0,
      "id": 28359277,
      "score": 1,
      "time": 1630348800,
      "title": "We Don't Do Daily Stand-Ups at Supercede",
      "type": "story",
      "url": "https://jezenthomas.com/why-we-dont-do-daily-stand-ups-at-supercede/"
    },
    {
      "by": "neom",
      "descendants": 1,
      "id": 28359259,
      "kids": [
        28359292
      ],
      "score": 1,
      "time": 1630348679,
      "title": "Theranos founder claims abuse by ex-boyfriend in fraud trial: court filings",
      "type": "story",
      "url": "https://www.ctvnews.ca/world/theranos-founder-claims-abuse-by-ex-boyfriend-in-fraud-trial-court-filings-1.5565456"
    },
    {
      "by": "fsagx",
      "descendants": 0,
      "id": 28359243,
      "score": 2,
      "time": 1630348602,
      "title": "JING OS Linux Tablet Review",
      "type": "story",
      "url": "https://tuxphones.com/jingos-linux-tablet-review-part-1/"
    },
    {
      "by": "johntfella",
      "descendants": 0,
      "id": 28359217,
      "score": 2,
      "time": 1630348472,
      "title": "The Masked Ball of Cowardice",
      "type": "story",
      "url": "https://www.tabletmag.com/sections/news/articles/masked-ball-cowardice"
    },
    {
      "by": "ag8",
      "descendants": 0,
      "id": 28359203,
      "score": 1,
      "time": 1630348391,
      "title": "My questions about Próspera, answered",
      "type": "story",
      "url": "https://devonzuegel.com/post/prospera-faq"
    },
    {
      "by": "dsheu",
      "descendants": 0,
      "id": 28359202,
      "score": 1,
      "text": "Asking for a close friend who is research faculty at a medical institution:<p>He&#x27;s acquired a license to use a drug for novel applications, and works with a research lab that has shown some promising results on a few diseases (i.e. cancer)<p>He&#x27;s raising funds to run through clinical trials, but is somewhat in stealth mode.<p>I know for general tech VC (software), investors rarely if ever NDA&#x27;s to see Seed&#x2F;Series A decks.<p>How about for biotech&#x2F;pharma?",
      "time": 1630348388,
      "title": "Ask HN: NDA's for Biotech Startup Decks?",
      "type": "story"
    }
  ]
}